Increased risk of herpes zoster with tofacitinib treatment in Korean patients with rheumatoid arthritis: a single-center prospective study

We aimed to determine the risk of herpes zoster (HZ) in Korean rheumatoid arthritis (RA) patients on tofacitinib compared with tumor necrosis factor inhibitor (TNFi) treatment. From the prospective cohorts of RA patients who started tofacitinib or TNFi in an academic referral hospital in Korea, pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Yeo-Jin, Cho, Soo-Kyung, Kim, Hyoungyoung, Kim, Hye Won, Nam, Eunwoo, Jeon, Ja-Young, Yoo, Hyun-Jeong, Choi, Chan-Bum, Kim, Tae-Hwan, Jun, Jae-Bum, Bae, Sang-Cheol, Yoo, Dae Hyun, Sung, Yoon-Kyoung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10185531/
https://www.ncbi.nlm.nih.gov/pubmed/37188765
http://dx.doi.org/10.1038/s41598-023-33718-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10185531/
https://www.ncbi.nlm.nih.gov/pubmed/37188765
http://dx.doi.org/10.1038/s41598-023-33718-7

Ejemplares similares